Delayed progressive sensorineural hearing loss due to a novel compound heterozygous PTPRQ mutation in a Chinese patient
Journal of Clinical Laboratory Analysis · 2023
DOI: 10.1002/jcla.24886 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Clinical Laboratory Analysis, 2023. Verfasst von Yao Qin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Deafness, Hearing Loss, Hearing Loss, Sensorineural. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Municipal Science and Technology Commission, Beijing Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
The Protein tyrosine phosphatase receptor Q ( PTPRQ ) gene encodes a member of the type III receptor‐like protein tyrosine phosphatase family found in the stereocilium. Mutations in PTPRQ are mostly associated with deafness, autosomal recessive type 84 (DFNB 84), which usually results in progressive familial hearing loss.
Methods
A 25‐year‐old woman and her sister, both with postlingual‐delayed progressive sensorineural hearing loss, were examined. They were from a nonconsanguineous marriage and had no family history of hearing loss. New compound heterozygous PTPRQ gene mutations, nonsense (c.90C > A, p.Y30X) and splice (c.5426 + 1G > A) mutations in two PTPRQ alleles, were identified in the two sisters and were presumably autosomal recessive. The c.90C > A (p.Y30X) mutation was mapped to exon 2 of PTPRQ (NM_001145026).
Results
The c.90C > A mutation leads to a premature stop codon and a truncated protein. The c.5426 + 1G > A mutation leads to a truncated protein lacking the extracellular domain. Hence, both mutations were predicted to be pathogenic, leading to a deficiency of the extracellular, transmembrane, and phosphatase domains because of nonsense‐mediated mRNA degradation.
Conclusions
This study increases the spectrum of PTPRQ gene mutations that might be involved in delayed progressive autosomal recessive non‐syndromic hearing loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Head and Neck Surgery, Peking University First Hospital, Beijing, China.
- Department of Central Laboratory, Peking University First Hospital, Beijing, China.
- Department of Otolaryngology, Head and Neck Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Yao Qin
Förderung
- Beijing Municipal Science and Technology Commission
- Beijing Natural Science Foundation
- National Natural Science Foundation of China
- Peking University First Hospital Seed Foundation
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Qin, Y., Ma, Y., Zeng, Z., Zhong, Z., Qi, Y., & Liu, Y. (2023). Delayed progressive sensorineural hearing loss due to a novel compound heterozygous PTPRQ mutation in a Chinese patient. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.24886
Vancouver
Qin Y, Ma Y, Zeng Z, Zhong Z, Qi Y, Liu Y. Delayed progressive sensorineural hearing loss due to a novel compound heterozygous PTPRQ mutation in a Chinese patient. Journal of Clinical Laboratory Analysis. 2023. doi:10.1002/jcla.24886
BibTeX
@article{Qin2023,
author = {Qin, Yao and Ma, Yi'nan and Zeng, Zhen'gang and Zhong, Zhen and Qi, Yu and Liu, Yuhe},
title = {Delayed progressive sensorineural hearing loss due to a novel compound heterozygous PTPRQ mutation in a Chinese patient},
journal = {Journal of Clinical Laboratory Analysis},
year = {2023},
doi = {10.1002/jcla.24886}
}
EUVIMED